False information is being spread online about Kimer Med. This is causing unnecessary fear and alarm in the community.

A statement from Kimer Med CEO, Rick Kiessig, in response to online misinformation.

Chronic viral disease represent a significant and often overlooked burden on global health, characterised by diverse manifestations, complex pathogenesis and profound socio-economic implications.

The number of people living with dementia in New Zealand is expected to double over the next 20 years, an alarming trend that is reflected throughout the world. This represents not just a lot of human suffering, but a major health and economic issue.

On March 21, 2024, the UK Government’s Chief Scientific Advisor, Dame Angela McLean, chaired a roundtable discussion with a list of esteemed scientists from around the world to answer these three questions.

Biotech company Kimer Med is one big step closer towards its goal of eradicating viral disease and providing protection against future viral pandemics.

Kimer Med’s success against devastating viruses increases at pace, as need for pandemic preparedness intensifies

While standard antiviral therapies can suppress active viral replication, there’s no existing treatment that can eradicate latent infection, meaning there’s no cure for many prevalent viral diseases.

New Zealand’s Infectious Disease Research Platform ‘Te Niwha’ has released a substantial report entitled “Likely future pandemic agents and scenarios: An epidemiological and public health framework”.

Apoptosis is a natural and necessary process that occurs in the human body. It is sometimes referred to as “programmed cell death”.

Kimer Med co-founder and CEO, Rick Kiessig, was awarded Entrepreneur of the Year at the GEN NZ 2023 Entrepreneurial Ecosystem Awards held at GridAKL Futures Lab in Auckland last night.

The JC virus is one of those viruses that you’ll probably never hear about, until you find it that it might kill you!

Flaviviruses are a family of viruses that cause a range of serious human diseases such as Dengue fever, Zika virus fever and Japanese encephalitis. They are important to understand due to their impact on global health and the increasing frequency of outbreaks, driven by climate and environmental factors.

Attended by Kimer Med’s Business Development Manager, Dr Mike Schmidt, the annual Dengue Summit presents an opportunity for Dengue researchers, health professionals and others in the field to come together and share the latest information in the hope that it will lead to better prevention and control of this significant global health threat.

Occasionally, we see objections to antiviral drugs, especially those targeting broad spectrum efficacy, based on the idea that viruses can be beneficial to human life. Usually however, these objections rest on a straw man.